Classic Layout

German investor morale tumbles over trade war worries

Bloomberg The euro area’s economic expansion is standing on increasingly shaky ground after reports showed German investor confidence tumbling to its lowest level since late 2012 and the risk of a recession in the nation jumping. The sentiment gauge from ZEW showed more investors now see a worsening in Europe’s largest economy than forecast an improvement, a mood swing that ...

Read More »

Sanofi to sell generics arm for $2.4bn

Bloomberg Sanofi plans to sell its European generic-drug unit to buyout firm Advent International Corp. for 1.9 billion euros ($2.4 billion) as part of a broader move by Chief Executive Officer Olivier Brandicourt to focus resources on biotechnology and new medicines. Advent has made a binding and fully financed offer, and the companies are in exclusive negotiations, Paris-based Sanofi said ...

Read More »

US home construction up

Bloomberg US new-home construction rose by more than forecast in March on a rebound in multifamily starts, giving a boost to first-quarter economic growth, government figures showed on Tuesday. The results show a tight job market, improved finances and consumers’ elevated confidence to purchase big-ticket items are supporting construction. That means homebuilding probably contributed to economic growth for the second ...

Read More »

UnitedHealth profit beats estimates

Reuters UnitedHealth Group Inc on Tuesday posted a quarterly profit that beat Wall Street estimates, fuelled by growth in its core insurance and health-services businesses and raised its earnings forecast for the year. Shares of UnitedHealth rose 1.3 percent to $233.25 in premarket trading. The largest US health insurer has been adding more physicians through a series of acquisitions, helping ...

Read More »

J&J raises full-year sales forecast

Reuters Johnson & Johnson reported a better-than-expected first-quarter profit on Tuesday and raised its full-year sales forecast, helped by growing demand for its cancer drugs. J&J’s pharmaceuticals sales rose 19.4 percent to $9.84 billion, driven by sales of its cancer drugs such as Darzalex, Imbruvica and Zytiga that rose 45 percent to $2.31 billion in the quarter. J&J raised its ...

Read More »

Draghi’s high-class problem rears its head as ECB views exit

Bloomberg European Central Bank officials are starting to consider a topic President Mario Draghi dismissed as a “high-class problem” — whether to let the economy run hot. Even with recent signs of a slowdown, the euro-zone economy is growing faster than its long-term trend. Allowing that boom to continue even at the cost of higher inflation is arguably one way ...

Read More »

Croatia central banker sees lasting benefits from adopting euro

Bloomberg Adopting the euro would offer “numerous and lasting” benefits for Croatia’s economy, central bank governor Boris Vujcic told Reuters, although he declined to indicate when it might enter the single currency’s ERM-2 “waiting room”. Prime Minister Andrej Plenkovic said in October that he wanted the newest European Union member to start using the euro within seven or eight years. ...

Read More »

Barclays sounds out clients about trading cryptocurrency

Bloomberg Barclays Plc has been gauging clients’ interest in the British bank starting a cryptocurrency trading desk, potentially joining Goldman Sachs Group Inc. in pioneering a new business on Wall Street, according to people with knowledge of the matter. Barclays has so far only done a preliminary assessment of demand and feasibility, said the people, who asked not to be ...

Read More »
Send this to a friend